A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

Clinical trial NCT02083627 · COMPLETED

Trial details

NCT number: NCT02083627
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug-Drug Interaction (DDI)Intestinal Absorption Healthy Subjects Pharmacokinetics of Rosuvastatin Pharmacokinetics of Fidaxomicin

Start date: 2013-02-01
Primary completion: 2013-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.